Utility of combined indexes of electrocardiography and echocardiography in the diagnosis of biopsy proven primary cardiac amyloidosis

Annals of Noninvasive Electrocardiology

Volumn 16, Issue 1, 2011, Pages 25-29

  Cheng, Zhongwei ^a   Kang, Lin ^a   Tian, Zhuang ^a   Chen, Weiyun ^a   Guo, Wenjuan ^a   Xu, Jia ^a   Chen, Taibo ^a   Fang, Ligang ^a   Zeng, Yong ^a   Cheng, Kang'An ^a   Fang, Quan ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

cardiac amyloidosis; echocardiography; electrocardiography

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART AMYLOIDOSIS; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART SIZE; HEART VENTRICLE SEPTUM; HEART VENTRICLE SIZE; HUMAN; MALE; PERICARDIAL EFFUSION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AMYLOIDOSIS; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 79251520984     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2010.00403.x     Document Type: Article

References (14)

1. Picano E, Pinamonti B, Ferdeghini EM, et al,. Two-dimensional echocardiography in myocardial amyloidosis. Echocardiography 1991; 8: 253-259.
2. Austin BA, Duffy B, Tan C, et al,. Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis. Am J Cardiol 2009; 103: 1429-1433.
3. Falk RH, Comenzo RL, Skinner M,. The systemic amyloidoses. N Engl J Med 1997; 337: 898-909.
4. Falk RH,. Diagnosis and management of the cardiac amyloidoses. Circulation 2005; 112: 2047-2060.
5. Gardin JM, Adams DB, Douglas PS, et al.,; American Society of Echocardiography. Recommendations for a standardized report for adult transthoracic echocardiography: A report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr 2002; 15: 275-290.
6. Murtagh B, Hammill SC, Gertz MA, et al,. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol 2005; 95: 535-537.
7. Rapezzi C, Merlini G, Quarta CC, et al,. Systemic cardiac amyloidoses: Disease profiles and clinical courses of the 3 main types. Circulation 2009; 120: 1203-1212.
8. Siqueira-Filho AG, Cunha CL, Tajik AJ, et al,. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation 1981; 63: 188-196.
9. Rahman JE, Helou EF, Gelzer-Bell R, et al,. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 2004; 43: 410-415.
10. Carroll JD, Gaasch WH, McAdam KP,. Amyloid cardiomyopathy: Characterization by a distinctive voltage/mass relation. Am J Cardiol 1982; 49: 9-13.
11. Selvanayagam JB, Hawkins PN, Paul B, et al,. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 2007; 50: 2101-2110.
12. Dubrey SW, Cha K, Anderson J, et al,. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998; 91: 141-157.
13. Kyle RA, Gertz MA,. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45-59.
14. Cacoub P, Axler O, De Zuttere D, et al,. Amyloidosis and cardiac involvement. Ann Med Interne (Paris) 2000; 151: 611-617.